Avelumab Biosimilar – Anti-PD-L1 mAb – Research Grade

제품 번호

PX-TA1003

제품 특징

Product name	Avelumab Biosimilar - Anti-PD-L1 mAb - Research Grade
Source	DrugBank DB11945
Species	Human
Expression system	Mammalian cells
Molecular weight	LC: 22kDa HC: 49kDa
Purity	>85%
Buffer	PBS pH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	4°C for short term; -20°C for long term
Brand	ProteoGenix
Aliases /Synonyms	Avelumab,Avelumab,PD-L1,anti-PD-L1
Reference	PX-TA1003
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1
Clonality	Monoclonal Antibody

Description of Avelumab Biosimilar - Anti-PD-L1 mAb - Research Grade

General information about Avelumab

Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.

QC & Validation Data

SDS-PAGE for Avelumab Biosimilar - Anti-PD-L1 mAb

Avelumab Biosimilar - Anti-PD-L1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Publications

Ruchi Saxena, Ryan Bushey, Michael Campa et al. Creation of a Favorable Antitumor Microenvironment by the Anti-Complement Factor H Antibody GT103, 06 September 2022, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-2001920/v1]

ProteoGenix의 모든 제품들을 만나보세요!

Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"

제품소개

제품상세페이지

Proteogenix

[Proteogenix] Avelumab Biosimilar – Anti-PD-L1 mAb – Research Grade

Cat-No. PX-TA1003

Avelumab Biosimilar – Anti-PD-L1 mAb – Research Grade

Description of Avelumab Biosimilar - Anti-PD-L1 mAb - Research Grade

General information about Avelumab

SDS-PAGE for Avelumab Biosimilar - Anti-PD-L1 mAb